• Home
  • Actinium-225 targeted alpha particle therapy for prostate cancer.

Actinium-225 targeted alpha particle therapy for prostate cancer.

Author List
Bidkar AP, Zerefa L, Yadav S, VanBrocklin HF, Flavell RR
Publication
Theranostics
Publication ID (Profile URL)
https://researcherprofiles.org/profile/522584065
Publication Year
2024
PubMed ID
38773983
Publication Title
Bidkar AP, Zerefa L, Yadav S, VanBrocklin HF, Flavell RR. Actinium-225 targeted alpha particle therapy for prostate cancer. Theranostics. 2024; 14(7):2969-2992.